We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Partners on Five-Year Program to Monitor Vaccine Risks, Benefits
EMA Partners on Five-Year Program to Monitor Vaccine Risks, Benefits
The European Medicines Agency has launched a collaborative five-year program with the goal of developing a blueprint for a pan-European framework for monitoring the benefits and risks of vaccines throughout their lifecycles.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor